The US Army Medical Command is seeking to procure 18 boxes of polyvalent snake antivenom targeting 25 species of Sub-Saharan African snakes through a solicitation issued by the US Army Medical Materiel Center Europe. The antivenom must be licensed for human use, freeze-dried, stable in extreme temperatures, and designed for direct intravenous administration in low-resource environments. The contract will be awarded using a Lowest Price Technically Acceptable (LPTA) evaluation process, with quoters required to submit a technical capability statement demonstrating compliance with salient characteristics. Potential bidders must be registered in the System for Award Management (SAM) and adhere to the submission guidelines. The quote submission deadline is 11 April 2025 at 12:00 PM, with a planned delivery date of 15 May 2025.

The solicitation is designated as a Women-Owned Small Business (WOSB) set-aside and structured as a commercial item acquisition under FAR Part 12 and Part 13.5 Simplified Procedures. The contract will be performed at the Kaiserslautern Army Depot in Germany, with the procurement falling under the NAICS category of Surgical Appliance and Supplies Manufacturing (339113) and PSC category of Medical and Surgical Instruments, Equipment, and Supplies (6515). The specific solicitation number is W9114F25QA027, and the procurement covers a comprehensive antivenom solution designed to address medical treatment needs for a wide range of venomous snake species in Sub-Saharan Africa. While specific budget details are not disclosed, the procurement represents a targeted medical supply acquisition aimed at enhancing medical readiness and treatment capabilities in potentially challenging environmental conditions.

Snake Antivenom

Opportunity facts

About this opportunity

Notice text

Files

Work this opportunity